Oncogene addiction: Resetting the safety switch?

Oncotarget

Volumn 5, Issue 18, 2014, Pages 7986-7987

  Li, Yulin ^b   Choi, Peter S ^b   Felsher, Dean W ^a  

^a STANFORD UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

B CELL TRANSLOCATION GENE 1; BIM PROTEIN; HIGH MOBILITY GROUP BOX TRANSCRIPTION 1; PEPTIDES AND PROTEINS; PROTEIN ARGININE METHYLTRANSFERASE; PROTEIN ARGININE METHYLTRANSFERASE 1; SUPPRESSOR OF VARIEGATION 4 20 HOMOLOG 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SIN3B; UNCLASSIFIED DRUG; MICRORNA; MYC PROTEIN;

APOPTOSIS; CANCER CELL; CELL AGING; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; DOWN REGULATION; EDITORIAL; GENE; GENE EXPRESSION; GENE INACTIVATION; GENE INDUCTION; HUMAN; MIR 17 92 GENE; ONCOGENE MYC; SIGNAL TRANSDUCTION; ANIMAL; GENETICS; LYMPHOMA; METABOLISM; PHYSIOLOGY;

ANIMALS; CELL PROLIFERATION; CELL SURVIVAL; LYMPHOMA; MICRORNAS; PROTO-ONCOGENE PROTEINS C-MYC;

EID: 84907991954     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.2474     Document Type: Editorial

References (7)

1. Weinstein IB. Science. 2002; 297:63.
2. Kaelin WG, Jr. Nat Rev Cancer. 2005; 5:689.
3. Kamb A. Mol Biol Cell. 2003; 14:2201.
4. Sharma SV, et al. Clin Cancer Res. 2006; 12:4392s.
5. Wu CH, et al. Proc Natl Acad Sci U S A. 2007; 104:13028.
6. Felsher DW. Cancer Res. 2008; 68:3081.
7. Li Y, et al. Cancer Cell. 2014; 26:262.